Ten-year outcome of patients with acute myeloid leukemia not treated with allogeneic transplantation in first complete remission
Sumithira Vasu(The Ohio State University), Clara D. Bloomfield(North Shore University Hospital), Gail J. Roboz(Cornell University), Heiko Becker(University of Freiburg), Klaus H. Metzeler(University Hospital Leipzig), Maria R. Baer(University of Maryland, Baltimore), Dimitrios Papaioannou(NYU Langone Health), Jessica Kohlschmidt(The Ohio State University), Jonathan E. Kolitz(Memorial Sloan Kettering Cancer Center), Richard M. Stone(Dana-Farber Cancer Institute), Andrew J. Carroll(University of Alabama at Birmingham), Krzysztof Mrózek(The Ohio State University), Deedra Nicolet(The Ohio State University), Ann‐Kathrin Eisfeld, Joseph O. Moore(Cancer Institute (WIA)), John C. Byrd(University of Cincinnati), Bayard L. Powell(Atrium Health Wake Forest Baptist), Lisa J. Sterling(The Ohio State University)
Cited by 111
Related Papers
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
|Nature|2000|10k
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k